MAJOR CONTRACT WIN IN THE US GIVES COMPUMEDICS ACCESS TO 1400 HOSPITALS

• Compumedics signs 3-year agreement with HealthTrust Purchasing Group as a preferred vendor for the purchase of sleep diagnostic and neuro-monitoring systems to their member group
• HealthTrust membership comprises nearly 1,400 hospitals and 10,600 non-acute healthcare facilities across America

Compumedics Limited (ASX: CMP) is pleased to announce that its wholly owned subsidiary, Compumedics USA, Inc. has won a 3-year agreement with HealthTrust Purchasing Group (“HealthTrust”) for the purchase of Compumedics sleep diagnostic and neuro-monitoring systems. Under this agreement HealthTrust will provide its members with access to purchase Compumedics’ range of sleep diagnostic and neuro-monitoring systems.

The HealthTrust member network consists of 1,400 hospitals and 10,600 non-acute healthcare facilities across America. Compumedics is one of only two vendors that have been given preferred vendor status for sleep diagnostic and neuro-monitoring systems to the HealthTrust Purchasing Group.

For more than 25 years, health care providers worldwide have chosen Compumedics’ comprehensive and innovative line of sleep diagnostic and neuro-monitoring systems to aid in the diagnosis, information and treatment of their patients. The HealthTrust contract confirms the enduring nature of Compumedics proposition to deliver innovative solutions to market.

Compumedics remains highly focused on growing the Group through:

· -Expansion of the Company’s existing products to all key global markets

· -Expansion of sales of the Company’s existing products into emerging markets, particularly China; and

· -Continuing the initial penetration of the neuro-diagnostic market, particularly the US, with Compumedics’ range of neuro-diagnostic products, including the Neuvo® LTEM (long-term EEG-monitoring) system

In commenting on this new deal for the Company, Executive Chairman & CEO, Dr David Burton said:

“We are delighted to announce another substantial contract win for Compumedics. HealthTrust Purchasing Group is one of the major member networks for hospitals in the US market and to sign a 3-year agreement with them, giving access to 1,400 hospitals is a significant milestone achievement for our Company.”

About Compumedics Limited

Compumedics Limited (ASX: CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The Company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including Americas; Australia and Asia Pacific; and Europe and the Middle East.

Executive Chairman, Dr David Burton, founded Compumedics in 1987. In the same year the Company successfully designed and installed the first Australian, fully computerised Sleep Clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets. Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards and accolades including Australia’s exporter of the year and has been recognised as a Top 100 Innovatorby the both German and Australian Governments.

For further background please visit: www.compumedics.com

For further information please contact:

Dr David Burton, Executive Chairman, CEO

Compumedics Limited

T: + 61 3 8420 7300, F: +61 3 8420 7399
Mr David Lawson, Executive Director, CFO

Compumedics Limited

T: + 61 3 8420 7300, F: +61 3 8420 7399

dlawson@compumedics.com.au

For investor relations and media enquiries:
Rod North, Managing Director,

Bourse Communications Pty Ltd

T: +61 3 9510 8309, M: 0408 670 706

E:rod@boursecommunications.com.au